Need Help? Chat Online or Toll Free: 1-800-891-0844
Cart (0)

What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Lidex Ointment (Fluocinonide) (Lyderm in Canada)

We don't have this brand product yet!

Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.

Sign Up
Generic

What is a Generic?

Generic Equivalent - Lidex Ointment (Fluocinonide) (Lyderm in Canada)

Prescription Required

Strength
Qty
0.05% 60g
0.05% 100g

  • Related Products & Conditions

  • Product Details

    Description

    Lidex® (fluocinonide) Ointment 0.05% is a potent topical corticosteroid formulated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Fluocinonide exhibits anti-inflammatory, antipruritic, and vasoconstrictive properties, making it effective in reducing symptoms associated with various skin conditions.

    Fact Table

    Formula

    C26H32F2O6

    License

    US FDA

    Bioavailability

    <1% (topical, intact skin)

    Legal status

    Rx-only

    Chemical Name

    Fluocinonide

    Elimination half-life

    Unknown (minimal systemic absorption)

    Dosage (Strength)

    0.05% ointment

    Pregnancy

    Category C – Use only if clearly needed

    Brands

    Lidex, Lyderm, Fluonex, Topicon

    Protein binding

    Unknown

    PubChem CID

    443975

    MedlinePlus

    a682799

    ChEBI

    31499

    ATC code

    D07AC08

    DrugBank

    DB01013

    KEGG

    D00569

    Routes of administration

    Topical (skin)

    Directions

    Apply a thin film of Lidex Ointment to the affected area two to four times daily, depending on the severity of the condition. Gently rub in the ointment until it is evenly distributed. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions; however, if an infection develops, discontinue the use of occlusive dressings and initiate appropriate antimicrobial therapy.

    Ingredients

    • Active Ingredient: Fluocinonide 0.05%.
    • Inactive Ingredients: The specific inactive ingredients in Lidex Ointment are not detailed in the provided sources. For a comprehensive list, please refer to the product's packaging or consult the prescribing information.

    Contraindications

    Lidex Ointment is contraindicated in patients with:

    • Untreated bacterial, tubercular, fungal, or viral infections of the skin, including herpes simplex, vaccinia, and varicella.
    • Known hypersensitivity to fluocinonide or any components of the formulation.

    Cautions

    • Systemic Absorption: Topical corticosteroids can be absorbed in sufficient amounts to produce systemic effects, including reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria. Conditions that augment systemic absorption include the application of potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.
    • Pediatric Use: Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity. Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.
    • Local Adverse Reactions: Prolonged use may produce atrophy of the skin and subcutaneous tissues, particularly on flexor surfaces and on the face. If irritation develops, discontinue use and institute appropriate therapy.

    Side Effects

    The following local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings:

    • Burning
    • Itching
    • Irritation
    • Dryness
    • Folliculitis
    • Hypertrichosis
    • Acneiform eruptions
    • Hypopigmentation
    • Perioral dermatitis
    • Allergic contact dermatitis
    • Maceration of the skin
    • Secondary infection
    • Skin atrophy
    • Striae
    • Miliaria

    If any of these side effects occur, discontinue use and consult your healthcare provider.

    IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

    Product Code : 1604

  • Product Reviews